StocksGlaxoSmithKlineGSK.L

GSK.L

GlaxoSmithKline

1317.02 10.78 (0.83%)
Prices By Xignite, in GBX Market Closed
Trade
S
1317.02
B
1321.38

Overview

Prev Close1317.02
Day's Range 1284.27 - 1321.61
52 Week Range 1281.08 - 2278.20
Average Volume (3m)7.21M
1-Year Return-24.07%
Beta0.1291
Market Cap53.11B
P/E Ratio11.62
Revenue35.31B
EPS1.1354
Dividend (Yield)0.8625 (6.55%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.725/04/202206/07/202213/09/20221400.001600.001800.002000.002200.002400.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Emma N. Walmsley
Employees 90,096

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: GlaxoSmithKline's revenues increased by 0.04% and amounted to 34.11B. Net income decreased by 20.23% to 5.10B. Net assets increased by 2.57% to 21.34B and EPS decreased from 1.14 to 0.87.
GSK.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
65.15%
Net Profit Margin
12.06%
Operating Margin
20.63%
Return On Investment
13.24%
09/21
12/21
03/22
06/22
Total Revenue
9.08B
9.53B
9.78B
6.93B
Gross Profit
6.25B
5.88B
6.11B
4.77B
Operating Income
2.18B